PL03.09 IMpower010:Overall Survival Interim Analysis of a Phase III Study of Atezolizumab vs Best Supportive Care in Resected NSCLC
暂无分享，去创建一个
A. Chella | H. Wakelee | C. Zhou | H. Kenmotsu | E. Vallières | A. Martínez-Martí | S. Sugawara | B. Gitlitz | E. Felip | Y. Fan | A. Akopov | E. Bennett | N. Altorki | I. Bondarenko | Y-M. Chen | F. Wu | Y. Deng | V. Mcnally | I. Vynnychenko | Y. Fan